Remote Ischemic Conditioning in Aneurysmal SAH
RESCUE-SAH
The Effect of Remote Ischemic Conditioning on Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized, Patient-assessor Blinded, Sham-controlled Pilot Study Investigating Effect on Clinical Outcome.
3 other identifiers
interventional
100
1 country
1
Brief Summary
The goal of this clinical trial is to examine the effect of limb occlusion therapy (remote ischemic conditioning, RIC) in subjects with aneurysmal subarachnoid hemorrhage. The main question it aims to answer is whether RIC can improve long-term recovery in participants with aneurysmal subarachnoid hemorrhage. Researchers will compare levels of functional independence in participants in the RIC-group to participants in the sham-group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2023
CompletedStudy Start
First participant enrolled
September 9, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2027
October 3, 2025
September 1, 2025
4.2 years
September 5, 2023
September 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical outcome after 6 months measured by modified Rankin scale score (0-6, Higher score indicates worse outcome)
Assessed by telephone interview. Patient assessor is blinded to intervention
Assessed 6 months after initial aneurysm rupture.
Secondary Outcomes (6)
Difference in Infarct growth
MRI performed 4-6 weeks after initial hemorrhage.
Clinical outcome after 14 days measured by modified Rankin scale score (0-6, Higher score indicates worse outcome)
14 days after initial hemorrhage.
Occurrence of delayed cerebral ischemia
Within first 14 days after initial hemorrhage.
Mortality after 3 months
Assessed at 3 months post initial hemorrhage
Mortality after 12 months
Assessed at 12 months post initial hemorrhage
- +1 more secondary outcomes
Study Arms (2)
Remote Ischemic Conditioning
EXPERIMENTALAfter randomization a large thigh blood pressure cuff will be placed on the lower limb. The cuff will be inflated to a pressure 30 mm Hg greater than the systolic arterial blood pressure measured by the patient's arterial line or upper limb blood pressure cuff. The adequate level of inflation will be confirmed by the absence of pulse in the ipsilateral pedal artery detected by palpation. If the pulse signal is still present, the cuff will be inflated further until it disappears. The cuff will remain inflated for 5 minutes. Then the cuff will be deflated and the limb allowed to re-perfuse for 5 minutes. The procedure will be repeated five times followed by reperfusion. The first session will be performed 24-72 hours after the initial hemorrhage, within the first 24 hours after treatment of aneurysm, and repeated every 24 hours, between 8-10 am, until post hemorrhagic day 14.
Sham-RIC
SHAM COMPARATORAfter randomization a large leg blood pressure cuff will be placed on the lower limb. This cuff will be inflated to 50 mm Hg only. The device will the be operated by trained staff. The cuff will remain inflated for 5 minutes, then the cuff will be deflated for 5 minutes. The procedure will be repeated for five cycles. The first session will be performed 48-72 hours after the initial hemorrhage, at least 24 hours after treatment of aneurysm and repeated every 24 hours, between 8-10 am, until post hemorrhagic day 14.
Interventions
5 Cycles of Remote Ischemic Conditioning performed on the leg. One cycle consists of 5 minutes of arterial occlusion followed by 5 minutes of reperfusion. The above is repeated daily for 14 days or until patient is discharged. Patients are randomized to either active Remote Ischemic Conditioning or Sham-treatment.
5 Cycles of sham-treatment performed on the leg. One cycle consists of 5 minutes of sham-treatment followed by 5 minutes of pause. The above is repeated daily for 14 days or until patient is discharged. Patients are randomized to either active Remote Ischemic Conditioning or Sham-treatment.
Eligibility Criteria
You may qualify if:
- Aneurysmal subarachnoid hemorrhage confirmed by computed tomography (CT) with aneurysm origin confirmed by computed tomography angiography (CTA) or digital subtraction angiography (DSA)
- Aneurysmal subarachnoid hemorrhage symptom-onset ≤ 3 days
- Aneurysm protected by clipping or coiling
- Independent in daily living before symptom onset (mRS ≤ 2)
You may not qualify if:
- Subarachnoid hemorrhage caused by a lesion other than cerebral aneurysm
- Symptomatic vasospasm at the time of enrollment
- Previous cerebral lesion e.g. symptomatic cerebral infarction (\>2cm), multiple sclerosis, symptomatic intracerebral hemorrhage, tumour, prior neurosurgery (excluding prior clipping or coiling of cold aneurysms without complications).
- History of severe peripheral vascular disease or signs of severe peripheral vascular disease on physical examination
- History of deep vein thrombosis or signs of deep vein thrombosis on physical examination
- Kidney involvement or prior kidney disease with an estimated glomerular filtration rate (eGFR) below safe levels for contrast infusion in relation to CT-perfusion.
- Concomitant other acute life-threatening medical or surgical condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurosurgery, Aarhus University Hospital
Aarhus N, Danmark, DK-8200, Denmark
Related Publications (2)
Hess DC, Blauenfeldt RA, Andersen G, Hougaard KD, Hoda MN, Ding Y, Ji X. Remote ischaemic conditioning-a new paradigm of self-protection in the brain. Nat Rev Neurol. 2015 Dec;11(12):698-710. doi: 10.1038/nrneurol.2015.223. Epub 2015 Nov 20.
PMID: 26585977BACKGROUNDGonzalez NR, Connolly M, Dusick JR, Bhakta H, Vespa P. Phase I clinical trial for the feasibility and safety of remote ischemic conditioning for aneurysmal subarachnoid hemorrhage. Neurosurgery. 2014 Nov;75(5):590-8; discussion 598. doi: 10.1227/NEU.0000000000000514.
PMID: 25072112BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Grethe Andersen, Prof., MD
Department of Neurology, Aarhus University Hospital
- STUDY DIRECTOR
Arzu Bilgin-Freiert, MD, PhD
Department of Neurosurgery
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Outcomes assessors are recruited from another department, and have not been involved with subjects prior to the telephone interview. Participants and outcome assessors are blinded to subject intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Consultant Neurologist, MD
Study Record Dates
First Submitted
September 5, 2023
First Posted
September 13, 2023
Study Start
September 9, 2023
Primary Completion (Estimated)
November 30, 2027
Study Completion (Estimated)
November 30, 2027
Last Updated
October 3, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Beginning 3 moths and ending 5 years following publication of results
- Access Criteria
- Proposals should be directed to kimoer@rm.dk. To gain access data requestors will need to sign a data processing agreement.
Individual participant data that underlie the results reported in this article after de-identification of participants